The 20 Best Polymorphous Low Grade Adenocarcinoma Doctors near San Francisco, CA

William Ryan is a General Surgeon in San Francisco, California. Dr. Ryan is rated as an Advanced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Sialadenitis, Salivary Duct Stones, Tongue Cancer, Endoscopy, and Laryngectomy. Dr. Ryan is currently accepting new patients.

Dr. Alain Algazi is a specialist in medical treatment – such as chemotherapy and immunotherapy – for patients with head and neck cancers, including head and neck squamous cell carcinoma, thyroid cancers and salivary gland cancers. He leads UCSF's program in medical therapy for head and neck cancers, and chairs the head and neck cancer research committee. In research, Algazi conducts clinical trials – studies that evaluate new therapies for head and neck cancers with an emphasis on approaches to improving the chances of long term remission in patients with incurable cancer using immunotherapy. He has also served the national study chair for clinical trials that give patients access to new medications and that provide new approaches of administering existing medications to improve their efficacy. Algazi earned his medical degree from the David Geffen School of Medicine at UCLA and completed a residency in internal medicine at Ronald Reagan UCLA Medical Center. He completed a fellowship in hematology-oncology at UCSF. Algazi is a member of the American Society of Clinical Oncology, Society for Immunotherapy for Cancer and American Association for Cancer Research. To reach Dr. Alain Algazi, please contact the head and neck medical oncology practice at (415) 353-9900. Dr. Algazi is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Polymorphous Low Grade Adenocarcinoma, and Glioma.

Caring, compassionate, and patient centric care. Dr. Meyer is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Angiosarcoma, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.

Caring, compassionate, and patient centered care. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Vulvar Cancer, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, and Astrocytoma.

Alan Kramer is an Oncologist in San Francisco, California. Dr. Kramer is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Nasopharyngeal Carcinoma, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer. Dr. Kramer is currently accepting new patients.

Hyunseok Kang is an Oncologist in San Francisco, California. Dr. Kang is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Nasopharyngeal Carcinoma, Laryngeal Cancer, Acinic Cell Carcinoma of Salivary Glands, and Glioma.

Born and raised in Hong Kong, Dr. Kevin K. Ho moved to the United States and pursued his undergraduate studies in Biomedical Engineering at Johns Hopkins. He then attended medical school at the University of California., Irvine and graduated with Distinctions in research. His work on electromechanical cartilage reshaping has been published in international journals and granted a US patent (7, 416, 550). Dr. Ho subsequently completed his residency in Otolaryngology, Head and Neck Surgery at the University of Texas Medical Branch.During his five-year residency training, he worked with numerous accomplished surgeons and clinicians, including sub-specialty rotations in the Alaska Native Medical Center and the Houston Texas Center. Dr. Ho is board certified by the American Board of Otolaryngology. Dr. Ho is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Familial Deafness, Infant Hearing Loss, Hearing Loss, and Laryngitis.

Donald Abrams is an Oncologist in San Francisco, California. Dr. Abrams is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Angiosarcoma, Small Cell Lung Cancer (SCLC), Inflammatory Breast Cancer, and Familial Prostate Cancer.

Roy Abendroth is a Radiologist and a Radiation Oncologist in San Francisco, California. Dr. Abendroth is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Nasopharyngeal Carcinoma, Anal Cancer, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Abendroth is currently accepting new patients.

Dr. Jason Chan is a radiation oncologist who specializes in treating head and neck cancers as well as thoracic cancer (cancers of the chest, including lung cancer). Chan has expertise in the full range of modern radiation therapy techniques, including intensity-modulated radiation therapy (which delivers precise radiation doses to a tumor or specific areas within the tumor), stereotactic radiotherapy (which uses particularly precise radiation doses and calls for fewer doses than traditional therapy), intraoperative radiotherapy (delivery of a large dose during surgery) and brachytherapy (in which a radiation source is placed inside the body). Chan earned his medical degree at the Warren Alpert Medical School of Brown University. He completed a residency in radiation oncology at UCSF, serving as chief resident. He then completed a fellowship in head and neck cancer at UCSF. Dr. Chan is rated as an Advanced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Nasopharyngeal Carcinoma, Olfactory Neuroblastoma, Teratocarcinosarcoma, and Thyroid Cancer.

Dr. Sue Yom is an expert in the radiation treatment and management of head, neck and lung cancers. In her research, Yom studies chemoradiation (a combination of chemotherapy and radiation) for these cancers. She also investigates image-guided radiation therapy and ways to reduce toxic effects using focused radiation techniques, emerging biological agents and radiation protectants. Yom earned her medical and doctoral degrees at the University of Pennsylvania. She completed a residency in radiation oncology at the MD Anderson Cancer Center. Yom has received numerous awards recognizing her commitment to patient care and patient-oriented research. Dr. Yom is rated as an Advanced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. Her top areas of expertise are Nasopharyngeal Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Merkel Cell Carcinoma, and Olfactory Neuroblastoma.

Dr. Patrick Ha is chief of the UCSF Division of Head and Neck Surgical Oncology. His expertise in patient care covers the full scope of head and neck surgery, with a focus on thyroid and parathyroid surgery as well as endoscopic approaches to throat cancer surgery. Ha's research is currently focused on molecular changes that occur in adenoid cystic carcinoma of the salivary gland. Ha received an undergraduate degree in biology from Harvard University, graduating magna cum laude. He obtained his medical degree from Johns Hopkins School of Medicine, graduating with membership in the Alpha Omega Alpha Honor Medical Society. He then completed his residency training and a postdoctoral fellowship at the otolaryngology department of Johns Hopkins, along with advanced fellowship training in head and neck oncologic surgery. Ha serves on the editorial board of several medical journals, including Oral Oncology. He is the Irwin Mark Jacobs and Joan Klein Jacobs Distinguished Professor in Head and Neck Cancer. Dr. Ha is rated as an Advanced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Adenoid Cystic Carcinoma, Salivary Gland Tumors, Tongue Cancer, Gastrostomy, and Laryngectomy.

Dr. P. Daniel Knott is director of facial cosmetic and reconstructive surgery within Otolaryngology–Head and Neck Surgery at UCSF. He has training and experience in facial aesthetics and microvascular surgery. His expertise includes treatment of facial paralysis, facial reconstruction following skin cancer, facial rejuvenation, minimally invasive techniques for filling out facial defects, rhinoplasty and free tissue transfer (moving tissue such as skin from one part of the body to another). In his research, Knott is working to develop new methods for reconstructing the palate (roof of the mouth) and the area of the eye orbit and upper jaw. He also studies microvascular treatment of osteonecrosis (when inadequate blood supply leads to death of bone tissue) and cartilage bioengineering (growing new cartilage tissue). Knott earned his medical degree at the University of California, San Diego School of Medicine and completed a five-year surgical residency at the Cleveland Clinic in otolaryngology–head and neck surgery. He also completed a fellowship in facial plastic and reconstructive surgery at Ronald Reagan UCLA Medical Center. Knott joined UCSF in 2011, after working at the Cleveland Clinic for 10 years. Knott is a fellow of the American College of Surgeons. He has won national awards for his research, which includes studies of head and neck tissue transplantation. Dr. Knott is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Facial Paralysis, Bell's Palsy, Recurrent Peripheral Facial Palsy, Tissue Biopsy, and Bone Graft.

Daniel Flis is an Otolaryngologist in San Francisco, California. Dr. Flis has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Polymorphous Low Grade Adenocarcinoma, Acinic Cell Carcinoma of Salivary Glands, Salivary Gland Tumors, Endoscopic Transnasal Transsphenoidal Surgery, and Balloon Sinuplasty.

Dr. Jolie L. Chang is an otolaryngologist who specializes in surgery to treat obstructive sleep apnea. She serves as chief of the UCSF Division of Sleep Surgery. She has expertise in sleep endoscopy (a technique for assessing the airway during sleep) and upper airway surgery, snoring surgery, palate surgery, tongue base surgery and hypoglossal nerve stimulation implant surgery (implanting a device that controls tongue movement in sleep). She also specializes in minimally invasive surgery for noncancerous salivary gland disorders (such as salivary stones) with sialendoscopy (a method of examining the salivary gland openings and removing obstructions using a very small endoscope). She treats salivary blockage from stones and salivary issues related to treatment with radioactive iodine. She is also an expert in ultrasound of the head and neck and ear, nose and throat disorders. Chang's research interests include decision making in health care and improvements for sleep apnea therapy and sialendoscopy. She has written on topics related to hearing loss, salivary obstruction symptoms and treatment, otolaryngology resident perspectives, and smell and taste changes related to COVID-19. She has also authored book chapters on sleep apnea therapies, salivary disorders and imaging for salivary glands. She serves as the director of resident research for otolaryngology – head and neck surgery. Chang graduated from the Massachusetts Institute of Technology with a bachelor's degree and a master of engineering degree in electrical engineering and computer science. She earned her medical degree and completed her residency in otolaryngology – head and neck surgery at UCSF. She is a fellow of the American College of Surgeons. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. Her top areas of expertise are Sialadenitis, Salivary Duct Stones, Obstructive Sleep Apnea, Endoscopy, and Stapedectomy.

Dr. Steve Braunstein is a radiation oncologist who cares for both adult and pediatric patients. He specializes in treating brain and spinal tumors, sarcomas, lymphoma and pediatric cancers. He also provides palliative radiotherapy to reduce symptoms in patients with advanced cancer. His expertise encompasses a number of technologies that use radiation as therapy, with a special focus on intraoperative radiotherapy and radiosurgery – using targeted high-dose radiation to destroy tumors, either as an alternative to surgical procedures or in combination with them. Braunstein's primary areas of research include improving radiation planning and treatment through the use of both gene marker analysis and advanced imaging technologies. He also studies how to improve the coordination, timing and delivery of health care that involves a variety of disciplines, including symptom management and cancer specialties. After earning his medical degree as well as a doctorate in biomedical sciences at New York University School of Medicine, Braunstein completed a residency in radiation oncology at UCSF. Braunstein is program director of UCSF's residency program and has a special interest in educating residents and medical students. He received a UCSF Medical Center Exceptional Physician Award in 2013. Braunstein serves as an editor for the International Journal of Radiation Oncology, Biology and Physics. He belongs to the American Society for Radiation Oncology, American Society of Clinical Oncology, Children's Oncology Group, Radiological Society of North America, North American Skull Base Society, International Gamma Knife Research Foundation and International Stereotactic Radiosurgery Society. He is active on committees within the National Cancer Institute, Children's Oncology Group and NRG Oncology. Dr. Braunstein is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Meningioma, Brain Tumor, Posterior Fossa Tumor, Gamma Knife Radiosurgery, and Osteotomy.

Dr. Ivan H. El-Sayed is a head and neck cancer surgeon. He specializes in treating benign and malignant lesions of the salivary glands, paranasal sinuses and skull base. El-Sayed's research interests include examining the value of sentinel node biopsy (a procedure to check whether cancer has spread) for head and neck cancer. He also is investigating potential uses of lasers and nanoparticles for diagnosing and treating cancer. El-Sayed earned his medical degree and completed a residency in otolaryngology at Boston University School of Medicine. He completed a fellowship in head and neck oncology at UCSF. Dr. El is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Endoscopy, and Turbinectomy.

Dr. Pamela N. Munster is a medical oncologist who cares for patients with breast cancer. Her roles include director of the early-phase clinical trials program for cancer research; co-director of the UCSF Center for BRCA Research; and co-leader of UCSF's program in developmental therapeutics, which focuses on innovative research to find treatments for advanced cancer. In her own research endeavors, Munster is interested in developing new targeted therapies for treatment-resistant cancer. She studies changes in gene expression and resistance to therapy. Her lab is involved in projects evaluating hormone therapies for breast cancer as well as therapies that engage the immune system to fight tumors. She has published in numerous scientific journals and lectured on topics in breast oncology, such as the management of metastatic breast cancer, breast cancer receptors, clinical trials and translational research (the process of applying study findings to patient care). She has a published memoir, “Twisting Fate: My Journey with BRCA – From Breast Cancer Doctor to Patient and Back.” Munster earned her medical degree from the University of Bern in Switzerland. She completed a residency in internal medicine at Indiana University Health, followed by a fellowship in medical hematology and oncology at Memorial Sloan Kettering Cancer Center, where she also served as faculty in the breast cancer program. Prior to joining UCSF, Munster worked for six years in the Moffitt Cancer Center's division of breast oncology and experimental therapeutics program, serving as scientific director of breast research and co-chair of the phase 1 clinical trial program. Dr. Munster is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. Her top areas of expertise are Breast Cancer, HER2 Negative Breast Cancer, Li-Fraumeni Syndrome, Prostatectomy, and Liver Embolization.

Dr. llya Likhterov is a surgeon who cares for patients with cancerous and noncancerous tumors of the head and neck, including those of the thyroid and parathyroid glands, salivary glands and other parts of the oral cavity, oropharynx (middle part of the throat), larynx (also known as the voice box) and skin. He has expertise in head and neck reconstructive surgery using microvascular free flap techniques, which restore function by transferring tissue and blood vessels from a healthy body area to the area needing repair. Likhterov earned his medical degree from Weill Cornell Medical College. He completed a residency in otolaryngology – head and neck surgery at UCSF, followed by a fellowship in head and neck and microvascular surgery at Mount Sinai Beth Israel. Dr. Likhterov is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Mikulicz Disease, Male Pattern Baldness, Tongue Cancer, Glossectomy, and Laryngectomy.

Dr. Katy K. Tsai is a medical oncologist who specializes in treating melanoma and other skin cancers. In addition to caring for patients, Tsai conducts clinical trials with two of her colleagues in cutaneous oncology, Dr. Adil Daud and Dr. Alain Algazi, seeking new and better therapies for patients with advanced melanoma or head and neck cancers. She also has a long-standing research interest in quality of life and outcomes for patients receiving immunotherapy. Tsai graduated with a degree in comparative literature from Brown University before earning her medical degree from Brown. She completed a residency in internal medicine at the University of North Carolina at Chapel Hill, followed by a fellowship in medical oncology at UCSF, where she served as chief fellow. Tsai is a member of the American Society of Clinical Oncology. She was born in Taiwan and raised in Toronto. Dr. Tsai is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. Her top areas of expertise are Melanoma, Melanoma of the Eye, Merkel Cell Carcinoma, and Uveal Melanoma.